SOURCES SOUGHT
B -- Rapporteur Services
- Notice Date
- 10/29/2009
- Notice Type
- Sources Sought
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2010-77844
- Archive Date
- 11/18/2009
- Point of Contact
- Tayaria L Smith,
- E-Mail Address
-
gqq4@cdc.gov
(gqq4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- Sources Sought Refrence # 2010-77844 The Coordinating Center for Infectious Diseases, The National Center for Immunization and Respiratory Diseases, of the Centers for Disease Control and Prevention is currently seeking sources for a contractor to provide the 2008 CDC Peer Review of Research and Scientific Programs policy (CDC-GA-2002-09, September 2008), Repparteur services. This award will be in accordance with FAR 13 using simplified acquisition procedures. Any organization or individual doing business with the government must be registered in the Central Contractor Registration (CCR). Follow link below for registration details. https://www.bpn.gov/ccr/default.aspx. Statement of Work TITLE: External Objective Review of the Global Routine Immunization Research Agenda I. BACKGROUND Childhood immunization is one of the most cost-effective of all health interventions. In the past two decades, immunization has prevented an estimated 20 million deaths globally from vaccine-preventable diseases. The United States has greatly reduced its burden of vaccine-preventable diseases (VIPs) through childhood immunization. However, U.S. children and adults remain at risk for VIPs largely due to their widespread occurrence in other countries. Globally, more than 2 million childhood deaths from VIPs are prevented each year (2004 estimate), and an additional 600,000 hepatitis B-related deaths from liver cirrhosis and hepatoma that may otherwise have occurred in adulthood are prevented. Each year, more than 130 million children are born worldwide who need immunization services. While 78% of the world's infants receive diphtheria-tetanus-pertussis vaccine (DTP3) - the benchmark indicator of annual routine immunization coverage - an estimated 27 million infants remain unvaccinated. One in six children is not vaccinated against tuberculosis; 1 in 4 is not vaccinated against measles, only half of the world's infants are fully immunized against hepatitis B, and 3 in 4 are not vaccinated against Hib disease. The negative impact of these gaps in immunization is enormous. An estimated 1.4 million children under age five died from the six major VPDs in 2004, with a further 1.1 million deaths from pneumococcal disease and rotavirus (vaccines that are available in the United States but rarely used in developing countries). Since 1991, CDC has provided substantial financial and technical support for polio eradication and measles elimination. CDC's yearly investment in global immunization has grown from $3.1 million to $143 million in 2009. In addition, CDC currently has more than 25 staff seconded to international health organizations, such as WHO, UNICEF, Pan American Health Organization, World Bank, and the American Red Cross, providing full-time technical and operational support to priority countries and regions. In keeping with this growth, CDC has a much broader role and greater influence in the field of global immunization than it did even five years ago. In addition to being a key partner in both the global polio eradication initiative and the Measles Initiative, CDC has played a critical role in developing the Global Immunization Vision and Strategy for 2006-2015 (GIVS); has a representative on the Global Alliance for Vaccines and Immunization (GAVI) working group; is an implementing partner in the Hib Initiative, charged by the GAVI Alliance to assist countries to make evidence-based decisions regarding the introduction of Hib vaccine into national programs; and is supporting pilot projects in three countries to strengthen the delivery of routine immunization. In addition, since CDC's last five-year strategic plan for global immunization, much has changed. There has been a renewed commitment from global partners for preventing VPDs among the world's children. This includes $4 billion from the International Finance Facility for Immunization (IFFIm) over the next 10 years and a $750 million investment from the Bill and Melinda Gates Foundation for 2006-2015. Both of these investments will support the GAVI Fund for several initiatives including supporting measles supplementary immunization activities (SIAs), strengthening immunization and health systems, eliminating maternal and neonatal tetanus, establishing the polio vaccine stockpile, improving access to underused vaccines, and speeding the development and introduction of new vaccines in GAVI-eligible countries. Investment cases for introduction of rotavirus vaccine and pneumococcal conjugate vaccine are under development. To protect children in the United States and reduce the global burden of VPDs, the Centers for Disease Control and Prevention (CDC) supports a broad range of programmatic and research efforts. CDC's experience working with domestic immunization partners provides valuable lessons and linkage with our international efforts and priorities. The Strengthening Immunization Systems Branch (SISB) strives to further this global immunization mission in the following ways: a. Strengthen immunization systems to deliver more vaccines, to more kids including older age groups; b. Assess the impact of immunization service delivery through surveillance, monitoring of vaccine coverage, and operations research; c. Test and evaluate new ideas to improve immunization services & their delivery, including integration with other interventions; d. Strengthen countries ability to do surveillance; and e. Help build capacity of countries to make decisions for effective, efficient, and sustainable immunization programs II. PURPOSE To find a qualified, internationally recognized professional in the field of global immunizations to act as rapporteur for the External Objective Review of the Global Routine Immunization Research Agenda, prepare the final report of the findings and recommendations of this Review, and present the report to the Global Immunization Division scientific and technical staff. III. SCOPE OF WORK The vendor will provide all labor, materials, and equipment required to complete the tasks outlined below. IV. TASKS TO BE PERFORMED (1) Service as rapporteur at the Routine Immunization External Objective review to be held November 12 - 13, 2009 in Atlanta, Ga (Building 106 of the Chamblee Campus, CDC, government to obtain necessary clearances for access to the building); this will include a) Taking notes during the meeting b) Collation of all notes, background material and presentation c) Sharing of draft with panelists, discussants and SISB staff for review d) Compilation of comments for final report (2) Presentation of the results of the Review to the Global Immunization Division, CDC in Atlanta, Ga on 17 November (12 Corporate Square, CDC, government to obtain necessary clearances for access to the building) and (3). Preparation of the final report, 2 hard copies and electronic copy in MS Word, for the External Objective Review of the Global Routine Immunization Research Agenda by 15 December 2009; the final report should include a) Executive summary b) Description of the review process, including objective, participants, presentations and agenda c) List of research priorities as discussed and recommended by the panel d) Table of panel recommendations for research priorities, including scores for feasibility. Importance and other criteria as determined by the panel. V. GOVERNMENT FURNISHED MATERIALS Not applicable. VI. PERIOD OF PERFORMANCE 1 month VII. DELIVERABLES The vendor shall provide the following deliverables to the Project Officer by the dates reflected below. All electronic files should be provided in MS Word format and provided via e-mail. Deliverables Date Required Full report of findings and recommendations of the External Objective Review. Report should include: a) Executive summary b) Description of the review process, including objective, participants, presentations and agenda c) List of research priorities as discussed and recommended by the panel d) Table of panel recommendations for research priorities, including scores for feasibility. Importance and other criteria as determined by the panel. Formal presentation of the Report in person to GID technical and scientific staff in Atlanta, Ga. At 12 Corporate Square VIII. PAYMENT TERMS (note if and how partial payments are authorized). Payments will be made in accordance with the line items established herein and in accordance with FAR 52.232-25, Prompt Payment, which states that the due date for making invoice payments shall be the 30th day after the designated billing office (see block 21 of the order) has received proper invoice or the 30th day after Government acceptance of the services performed by the vendor, whichever is later. IX. VENDOR QUALIFICATIONS 1) Extensive experience (20+ years) in multiple external program reviews and evaluations in the field of international immunizations. 2) Experience as rapporteur on multiple immunization program reviews. 3) Established history for synthesizing proceedings, preparing and presenting reports on routine immunization in developing countries in a timely manner. 4) Cannot be employed or affiliated with the Centers for Disease Control and Prevention or its global immunization partners - the World Health Organization, UNICEF, the GAVI Alliance, the United States Agency for International Development, Rotary International, American Red Cross, or the Bill and Melinda Gates Foundation. 5) Experience necessary to correctly compile and synthesize global routine immunization research information in a way that will be credible to the worldwide scientific community. No Request For Quote (RFQ) will been issued with this sources sought advertisments. This advertisement ends in 5 days in accordance with FAR 5.203 (A) (1).Any interested companies are welcome to submit their ability to provide these services, send via e-mail to, gqq4@cdc.gov. Please include reference number (2010-77844) on email inquiries. Please respond by Tuesday, November 3, 2009.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2010-77844/listing.html)
- Record
- SN01994914-W 20091031/091029235749-e8390b84dc126d0d49d9df77dd6a9ac5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |